dijous, 24 de juliol del 2014

Intersect ENT prices IPO at low end of range




Intersect ENT prices its initial public offering at $11 per share, the low end of its predicted range, hoping to raise $55 million when XENT shares hit the NASDAQ exchange today.






Intersect ENT said today that it's shares should hit the NASDAQ exchange at $11 apiece, the low end of the range, for expected proceeds of $55 million.


At that price, Intersect would command a market capitalization of roughly $267 million.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1x6NrAN

Cap comentari:

Publica un comentari a l'entrada